The Valley Desk

NCT02041260 · Interventional trial

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

Overall registry status Unknown

Phase 2

Conditions Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov